Explore New Insights from bit.bio - September Highlights!
Hi there,
This month, we’re thrilled to share our latest achievements and insights. We had the honour of hosting the UK’s Minister for Science, won the Life Science Innovation award, and are gearing up for major presentations at the Society for Neuroscience 2024. Plus, don’t miss updates on our Alzheimer's research advancements and upcoming events. Dive in!
What's new?
Welcomed Lord Vallance of Balham KCB, Minister for Science, Research and Innovation, at our headquarters
We were honoured to host the Minister at bit.bio, provide him with a tour of our labs and show him examples of the pioneering work we’re doing in cell programming for the democratisation of human cells. We appreciate the Government’s commitment to supporting the engineering biology industry and its impact on human health.
Awarded for Life Science Innovation at the 2024 Business Weekly Awards
We won Life Science Innovation awards at the 34th annual Business Weekly Awards 2024. The prestigious awards, celebrating excellence in the East of England's business community, were presented last month at a gala dinner held at Queens’ College, Cambridge.
Unveiling iPSC Advancements and ioCells Toolkit at the Society for Neuroscience 2024 Annual Conference
bit.bio's ioSensory Neurons pain research has been selected for presentation at the prestigious SfN Neuroscience 2024 press conference, chosen from over 10,500 submissions. At the event, bit.bio will also host an expert panel addressing the reproducibility crisis in neuroscience by promoting the standardisation of iPSC-derived cells. Additionally, a series of posters will showcase the application of ioCells in ALS/FTD, Huntington's disease, Multiple Sclerosis, and Alzheimer's research, highlighting the potential of these advanced neuronal models for disease modeling and target identification.
Expert insights
领英推荐
New Alzheimer's-relevant phenotype in ioGlutamatergic Neurons PSEN1 M146L
Alzheimer’s disease and dementia have no cure, and many of us know someone whose life has been affected by neurodegeneration.
We are therefore excited to show new functional data for our ioGlutamatergic Neurons carrying the PSEN1 M146L mutation, one of the most common mutations linked to early-onset Alzheimer’s disease. By providing in vitro disease models that offer an accurate representation of human biology, we hope to improve pre-clinical timelines and R&D success rates.
Upcoming events
Meet us at SfN 24!
A highlight of the neurosciences calendar has come around again! We are excited to attend Society for Neuroscience 24 in Chicago. We will host an important panel discussion on the growing need for standardisation in human cell models for neuroscience. Throughout the conference, we will present 7 posters that highlight new data describing the application of our ioCells toolkit across multiple neurological disease areas.
Come to booth #1545 to find out how bit.bio can transform your neuroscience research.
Meeting on the MESA!
We are excited to be part of the discussion on how to solve major challenges facing the gene and cell therapy sector today.
Make sure to catch our President and COO, Kathryn Penkus Corzo, as she describes how bit.bio's technology overcomes traditional barriers by enabling industrialised production of consistent iPSC-derived human cells.
Explore the full list of events we are attending here.